Acquiring Paltac, the largest consumer-goods wholesaler, in a share exchange (2005)

Not what you carry, but who you carry it to

What the 2005 combination addressed was not what a wholesaler carries but whom it carries to. Prescription medicines have only two kinds of customer, hospitals and dispensing pharmacies, and the price there is set by the biennial official revision and by the buyer’s purchasing power. When president Kumakura Sadatake reframed the company as moving “from a wholesaler defined by product category to one defined by retail format,” the reading behind it seems to have been that so long as the firm defined itself by the goods it handled, it would never recover the initiative on price. The spread of the drugstore — a sales floor where medicines and household goods sit on the same shelves — was what made the judgement possible.

The result was that a consumer-goods wholesaler with less than a third of the revenue came to sit just behind the drug business in operating profit. The margin the core business could not defend was earned by the company it had bought. In 2026, Medipal spent ¥192,455 million on the remaining 47.6% of that firm — one it had brought into the group at around ¥400 billion of sales — and ended the parent-child listing. Twenty-one years after the acquisition, Mediceo and PALTAC were back under a single capital structure.